NewsBenzinga노보 노디스크, 혈우병 치료제 EU 승인 획득···겸상적혈구병 치료제 승인 절차 진행 중 노보 노디스크, 혈우병 치료제 EU 승인 획득···겸상적혈구병 치료제 승인 절차 진행 중 Benzinga 2026.11.13 18:05 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report